Home > News > Nanogen to Present at UBS Global Life Sciences Conference
September 18th, 2003
Nanogen to Present at UBS Global Life Sciences Conference
Nanogen, Inc. a leading provider of molecular diagnostics, today announced Howard Birndorf, Nanogen's Chairman and CEO, will present an overview of the Company on Monday, September 22 at 10:00 a.m. EST during the UBS Global Life Sciences Conference. The conference will take place September 22-25 at The Plaza Hotel in New York City and will feature presentations by the life science industry's leading public companies, as well as a select group of top privately held biotechnology companies.
Graphene chips are close to significant commercialization October 1st, 2014
Production of Filters for Separation of Water from Petroleum Products in Iran October 1st, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014